BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 22543969)

  • 1. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging.
    Lim RP; Tuvia K; Hajdu CH; Losada M; Gupta R; Parikh T; Babb JS; Taouli B
    AJR Am J Roentgenol; 2010 May; 194(5):1288-95. PubMed ID: 20410416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.
    Lee SS; Park SH; Kim HJ; Kim SY; Kim MY; Kim DY; Suh DJ; Kim KM; Bae MH; Lee JY; Lee SG; Yu ES
    J Hepatol; 2010 Apr; 52(4):579-85. PubMed ID: 20185194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.
    Yokoo T; Bydder M; Hamilton G; Middleton MS; Gamst AC; Wolfson T; Hassanein T; Patton HM; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2009 Apr; 251(1):67-76. PubMed ID: 19221054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.
    Satkunasingham J; Besa C; Bane O; Shah A; de Oliveira A; Gilson WD; Kannengiesser S; Taouli B
    Eur J Radiol; 2015 Aug; 84(8):1452-1458. PubMed ID: 26047820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy.
    Park YS; Lee CH; Kim JH; Kim BH; Kim JH; Kim KA; Park CM
    Magn Reson Imaging; 2014 Sep; 32(7):886-90. PubMed ID: 24853467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation.
    Levin YS; Yokoo T; Wolfson T; Gamst AC; Collins J; Achmad EA; Hamilton G; Middleton MS; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2014 Mar; 39(3):567-75. PubMed ID: 23720420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration.
    Guiu B; Petit JM; Loffroy R; Aho S; Ben Salem D; Masson D; Robin I; Vergès B; Hillon P; Cercueil JP; Krausé D
    J Magn Reson Imaging; 2011 Jan; 33(1):119-27. PubMed ID: 21182129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation.
    Rinella ME; McCarthy R; Thakrar K; Finn JP; Rao SM; Koffron AJ; Abecassis M; Blei AT
    Liver Transpl; 2003 Aug; 9(8):851-6. PubMed ID: 12884199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0 T before hepatic surgery: reliable enough for making clinical decisions?
    Koelblinger C; Krššák M; Maresch J; Wrba F; Kaczirek K; Gruenberger T; Tamandl D; Ba-Ssalamah A; Berger-Kulemann V; Weber M; Schima W
    Eur J Radiol; 2012 Nov; 81(11):2990-5. PubMed ID: 22770582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
    Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
    Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of muscle fat in patients with low back pain: comparison of multi-echo MR imaging with single-voxel MR spectroscopy.
    Fischer MA; Nanz D; Shimakawa A; Schirmer T; Guggenberger R; Chhabra A; Carrino JA; Andreisek G
    Radiology; 2013 Feb; 266(2):555-63. PubMed ID: 23143025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.